Clinical Trial Update: Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab, methotrexate, procarbazine, and vincristine followed by high-dose chemotherapy with autologous stem-cell rescue in newly dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Cns Lymphomas

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Procarbazine (procarbazine)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: CNS Lymphoma, CNS Brain Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-04-01